Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST HCC CONTENT
Analyzing Nivolumab and Ipilimumab as HCC Therapy
Proactive Management Key to Addressing TKI Adverse Events in HCC
Diagnosis and Management of Unresectable HCC Using Clinical Criteria
Exploring Differences in Survival With Lenvatinib in Recent HCC Trials
Comparable Treatment Outcomes Are Observed for Child-Pugh B in HCC
How to Respond to Toxicities of Each Combination HCC Regimen
Lack of Biomarkers Complicates Selection of Immunotherapy in HCC
Atezolizumab/Bevacizumab Benefit Potentially Extends to Child-Pugh B HCC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement
